Literature DB >> 12755384

Effect of lipopolysaccharide on D-fructose transport across rabbit jejunum.

J García-Herrera1, B Abad, M J Rodríguez-Yoldi.   

Abstract

OBJECTIVE: To investigate alterations in the transport of D-fructose across the rabbit jejunum when the gut is exposed in vitro to lipopolysaccharide (LPS), an endotoxin causative agent of sepsis.
MATERIALS AND METHODS: D-fructose intestinal transport was assesed employing three techniques: sugar uptake measurements in rings of everted jejunum (micromol/D-fructose/ml cell water), transepithelial flux measurements in Ussing-type chambers (micromol D-fructose/cm2/h) and transport assays in preparation of brush border membrane vesicles (pmoles D-fructose/mg protein). Samples were taken from the bathing solution and from the extracts of the tissue for radioactivity counting.
RESULTS: Adding LPS (3 microg/ml) to tissue decreased the uptake and mucosal to serosal flux of 5 mM D-fructose across the enterocyte. LPS did not modify sugar uptake across brush border membrane vesicles. The inhibitory effect of LPS was suppressed by W-13 (5 x 10(-6) M), a Ca-calmodulin antagonist, and staurosporine (10(-7) and 10(-6) M) and GF-109203X (10(-6) M) a nonselective and selective protein kinase C (PKC) inhibitor respectively. Tumor Necrosis Factor (TNF-alpha), an immunoregulatory cytokine involved in septic responses occurring during bacterial infection at concentrations 3 x 10(-4) to 3 microg/ml, did not affect the sugar transport.
CONCLUSIONS: LPS can inhibit the intestinal uptake of D-fructose across the rabbit jejunum in vitro by intracellular processes related to PKC and calmodulin protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755384     DOI: 10.1007/s000110300069

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  8 in total

1.  Inhibition of intestinal ascorbic acid uptake by lipopolysaccharide is mediated via transcriptional mechanisms.

Authors:  Veedamali S Subramanian; Subrata Sabui; Hamid Moradi; Jonathan S Marchant; Hamid M Said
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-10-10       Impact factor: 3.747

2.  Understanding intestinal glucose transporter expression in obese compared to non-obese subjects.

Authors:  Rebecca A Deal; Yueming Tang; Reid Fletcher; Alfonso Torquati; Philip Omotosho
Journal:  Surg Endosc       Date:  2017-09-21       Impact factor: 4.584

3.  Lipopolysaccharide inhibits colonic biotin uptake via interference with membrane expression of its transporter: a role for a casein kinase 2-mediated pathway.

Authors:  Ram Lakhan; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-04       Impact factor: 4.249

4.  Effects of deoxynivalenol and lipopolysaccharide on electrophysiological parameters in growing pigs.

Authors:  Amal Halawa; Sven Dänicke; Susanne Kersten; Gerhard Breves
Journal:  Mycotoxin Res       Date:  2012-07-07       Impact factor: 3.833

5.  Intestinal D-galactose transport in an endotoxemia model in the rabbit.

Authors:  P Amador; J García-Herrera; M C Marca; J de la Osada; S Acín; M A Navarro; M T Salvador; M P Lostao; M J Rodríguez-Yoldi
Journal:  J Membr Biol       Date:  2007-06-12       Impact factor: 1.843

Review 6.  Regulation of the fructose transporter GLUT5 in health and disease.

Authors:  Veronique Douard; Ronaldo P Ferraris
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-08       Impact factor: 4.310

7.  Glucose transporter expression in the human colon.

Authors:  Flavia Merigo; Alessandro Brandolese; Sonia Facchin; Silvia Missaggia; Paolo Bernardi; Federico Boschi; Renata D'Incà; Edoardo Vincenzo Savarino; Andrea Sbarbati; Giacomo Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2018-02-21       Impact factor: 5.742

8.  Immunohistochemical Study of Glucose Transporter GLUT-5 in Duodenal Epithelium in Norm and in T-2 Mycotoxicosis.

Authors:  Piret Hussar; Florina Popovska-Percinic; Katerina Blagoevska; Tõnu Järveots; Ilmārs Dūrītis
Journal:  Foods       Date:  2020-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.